Cindy Pynadath, DO
Nephrology · Bronx, NYNPI 1205062460
Payments from drug & device makers
Across 24 payments — averaging $27.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$477
- Veloxis Pharmaceuticals, Inc.$48
- Sanofi$41
- Johnson & Johnson$39
- GSK$36
- Takeda Pharmaceuticals U.S.A., Inc.$17
What the payments were for
- Food & beverage$658100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $477 |
| Veloxis Pharmaceuticals, Inc. | 2 | $48 |
| Sanofi | 2 | $41 |
| Johnson & Johnson | 2 | $39 |
| GSK | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
How this compares
$658 in reported general payments places this provider in the 45th percentile of 935 nephrology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 160 | $105,509 |
| EliquisApixaban | 80 | $67,558 |
| Cinacalcet Hcl | 109 | $57,587 |
| Atovaquone | 73 | $40,813 |
| LokelmaSodium Zirconium Cyclosilicate | 34 | $33,396 |
| Envarsus XrTacrolimus | 30 | $26,265 |
| Valganciclovir Hcl | 56 | $15,838 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 42 | $14,512 |
| Tacrolimus | 86 | $11,583 |
| JardianceEmpagliflozin | 16 | $10,922 |
| Nifedipine ErNifedipine | 378 | $9,746 |
| Novolog FlexpenInsulin Aspart | 52 | $8,987 |
| Mycophenolate Mofetil | 44 | $7,223 |
| TradjentaLinagliptin | 14 | $7,034 |
| Mycophenolic AcidMycophenolate Sodium | 26 | $6,114 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Bronx
- Robert LynnBronx$2M
- Bruce SpinowitzBronx$837K
- Matthew AbramowitzBronx$749K
- Enver AkalinBronx$312K
- Chang XuBronx$257K
- Joel NeugartenBronx$256K
- Chaim CharytanBronx$204K
- Gill FreiBronx$188K
- Joji TokitaNew York$8.4M
- Krzysztof KirylukNew York$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.